Literature DB >> 24967470

Off-label, low-dose naltrexone for refractory chronic low back pain.

Babita Ghai, Dipika Bansal, Debasish Hota, Chirag Shashikant Shah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24967470     DOI： 10.1111/pme.12345

Source DB:  PubMed          Journal:  Pain Med        ISSN： 1526-2375            Impact factor:   3.750


× No keyword cloud information.
  3 in total

1.  Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin.

Authors:  Marissa J Metz; Caitlin M Daimon; Shane T Hentges
Journal:  eNeuro       Date:  2021-06-16

2.  Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.

Authors:  Gabriela Dieckmann; M Cuneyt Ozmen; Stephanie M Cox; Ryan C Engert; Pedram Hamrah
Journal:  Ocul Surf       Date:  2021-01-12       Impact factor: 6.268

3.  Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.

Authors:  Guttorm Raknes; Lars Småbrekke
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-03-29       Impact factor: 2.890
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.